Navigation Links
Carrington Reports on ISO 9001:2000 Inspection at Sabila Industrial in Costa Rica
Date:9/6/2007

- Sabila Industrial Originally Certified ISO in January 2003

- No Incidences of Nonconformance Found for Last Two Years - Auditors Stated, "First Time Any Company They Audited Performed at Such a

High Quality Level"

- Company Dedicated to Quality

IRVING, Texas, Sept. 6 /PRNewswire-FirstCall/ -- Carrington Laboratories, Inc. (Pink Sheets: CARN) today announced that its bulk pharmaceutical manufacturing subsidiary, Sabila Industrial, S.A., located in Liberia, Guanacaste, Costa Rica, has completed an annual ISO 9001:2000 re-certification inspection by the European Union's notified body, AENOR Internacional, S.A.U. of Madrid, Spain.

Mr. Jose Zuniga, Carrington's vice president of operations and manager of South American business, stated, "The Chief Inspector representing AENOR Internacional stated that this is the first time any company audited by his team has performed at such a high quality level that no nonconformances with ISO quality systems have been found over a two-year period. We at Carrington, and in particular Sabila Industrial, are delighted that our quality systems are recognized by an EU's notified body. We credit our frequent quality audits in Costa Rica and at our manufacturing facilities in Texas as key to our success."

Mr. Zuniga added, "Using organic certified plant materials, our Costa Rica plant manufactures the GelSite(R) polymer, the raw material key to the drug and vaccine delivery technology being developed by Carrington's biotech subsidiary DelSite Biotechnologies, Inc. GelSite(R) is used to make the influenza nasal powder vaccine for bird flu (H5N1). Additionally, our corporate site in Texas uses organic methods on its grounds, our Costa Rica farming operation is certified organic, and our raw material Manapol(R) is kosher certified. These certifications and quality systems are not inexpensive, but they show our dedication to quality. These inspecti
'/>"/>

SOURCE Carrington Laboratories, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. Sonic Foundry reports GAAP loss as Q2 revenues rise
3. Fiserv reports $113.5 million in Q1 profit
4. Third Wave reports net loss of $18.9M for 2006
5. Musicnotes reports 45 percent growth in 2006
6. Sonic Foundry reports net loss, higher revenue
7. Sonic Foundry reports first cash-positive quarter
8. Merge Healthcare reports $10.8M net loss in Q3
9. Third Wave reports $5.2M third quarter loss
10. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
11. Merge files financial reports by market opening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... NJ (PRWEB) January 22, 2015 ... technologies such as the Bioruptor® and complete solutions ... system for chromatin immunoprecipitation, alleviating the need for ... and controls needed for ChIP of histones or ...
(Date:1/22/2015)... PALO ALTO, Calif. , Jan. 22. 2015  Varian Medical ... equipment and software, has been honored for its commitment to ... most sustainable companies. Varian is the highest ranked healthcare equipment ... ranking, announced today during the World Economic Forum at ...
(Date:12/25/2014)... December 25, 2014 The report “Service ... Product Type & Provider Type - Global Advancements, Worldwide ... with an in-depth analysis and forecasting of revenues. ... through 221 pages and in-depth TOC on “Service Quality ...
(Date:12/24/2014)... , Dec. 24, 2014  Vermillion, Inc. (Nasdaq: ... gynecologic disease, announced today that the Company closed ... Oracle Investment Management, Jack W. Schuler , ... proceeds were $10.5 million, before offering expenses.  The ...
Breaking Biology Technology:Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2Varian Honored Among World's 100 Most Sustainable Corporations 2Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 2Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 3Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 4Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3
... A/S Summons Annual General Meeting Summary: Genmab ... COPENHAGEN, Denmark, April 7 Genmab A/S (OMX:,GEN) summon the ... CEST at the Radisson SAS Scandinavia Hotel, Amager Boulevard 70, ... Board of Directors on the Company,s activities during,the year., ...
... contains two different types of components: magnetic components, which ... operations. A University of Missouri researcher, as part of ... two functions in a single hybrid material. This new ... functions and is expected to permit the design of ...
... Angiotech Pharmaceuticals,Inc. (NASDAQ: ANPI , TSX: ANP), ... today that the first New Zealand patient,was treated ... in December 2007. A second patient was treated ... first drug-eluting stent for peripheral,arterial disease (PAD) and ...
Cached Biology Technology:Genmab A/S - Notice to Convene Annual General Meeting 2Genmab A/S - Notice to Convene Annual General Meeting 3Genmab A/S - Notice to Convene Annual General Meeting 4Genmab A/S - Notice to Convene Annual General Meeting 5Genmab A/S - Notice to Convene Annual General Meeting 6Genmab A/S - Notice to Convene Annual General Meeting 7Hybrid computer materials may lead to faster, cheaper technology 2Angiotech announces commercial launch of Cook Medical's Zilver(R) PTX(TM) drug-eluting peripheral stent in New Zealand 2Angiotech announces commercial launch of Cook Medical's Zilver(R) PTX(TM) drug-eluting peripheral stent in New Zealand 3Angiotech announces commercial launch of Cook Medical's Zilver(R) PTX(TM) drug-eluting peripheral stent in New Zealand 4
(Date:12/22/2014)... , Dec. 22, 2014  NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market, announces ... Apollo Robbins for the 2015 International CES debut of ... Robbins will be at the NXT-ID booth January 6th ...
(Date:12/19/2014)... , Dec. 18, 2014 Research and Markets ... "Micro Market Monitor: North America Perimeter Security Systems Market" ... The North American perimeter security market is ... to 2019. Although the U.S. market holds a larger share ...
(Date:12/17/2014)... 15, 2014 The Defense Logistics Agency is insourcing ... prevent counterfeit microcircuits from entering into its supply chain. ... microcircuit anti-counterfeit initiative dubbed DNA marking. The capability will ... reliability throughout the supply chain. The new quality control ...
Breaking Biology News(10 mins):NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 4Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3
... Leicester and University of California Los Angeles (UCLA) have ... in the body. They have filed two patents ... catalyst for lowering levels of ,bad, cholesterol. Two ... of the regulation of low-density lipoprotein (LDL) or "bad" ...
... have created a scientifically rigorous analogy that shows the similarities ... structure of a melody, proving that the structure of each ... The step-by-step comparison begins with the primary building blocks ... wave and moves up to the level of a ...
... magnetic resonance imaging measures were associated with prognostic ... imaging for prediction of disease prognosis and stratification ... data presented at the 2011 CTRC-AACR San Antonio ... "Breast cancers are heterogeneous, and different subtypes of ...
Cached Biology News:New advance announced in reducing 'bad' cholesterol 2Researchers link patterns seen in spider silk, melodies 2Researchers link patterns seen in spider silk, melodies 3MRI may be noninvasive method to measure breast cancer prognosis 2
Recognizes Kir4.1. The epitope does not share homology with any other known proteins.,SPECIES REACTIVITIES: The antibody is also expected to work with mouse and human due to sequence homology. Oth...
Mouse Anti-Amyloid beta [1-16], clone 6E10, Monoclonal Antibody...
Immunogen: Synthetic peptide: N(171) H G F L S A D Q QL I K(183) Storage: -20 C, Avoid Freeze/Thaw Cycles...
E1A (adenovirus early region 1)...
Biology Products: